University of California San Francisco

Dr. Ramin E. Beygui
Ramin
Beygui
MD, MSc, FACS

Professor of Surgery
Division of Cardiothoracic Surgery
Medical Director, Cardiothoracic Surgery
Washington Hospital Health System

Academic Office:
500 Parnassus Ave, MUW 405, Box 0118
San Francisco, CA 94143
Tel: (415) 353-8890
Email: [email protected]
Admin: [email protected]

Cardiac Surgery Program
400 Parnassus Avenue, Suite 501, Box 0957
San Francisco, CA 94143
Tel:415-353-1606
Fax: 415-353-1312

Cardiothoracic Surgery Program at WHHS
Washington Hosptial Healthcare System
39141 Civic Center Dr., Suite 335
Fremont, CA 94538
Tel: 510-248-1409 

Biography

Ramin E. Beygui, MD, MSc, FACS has concurrently joined UCSF School of Medicine Faculty in the division of Cardiothoracic Surgery and assumed the position of medical director of Cardiothoracic Surgery at Washington Hospital Health System. Dr Beygui has practiced cardiac, thoracic, and vascular surgery at UCLA and Stanford University Medical Centers before joining UCSF Faculty, and is practicing the entire scope of his experience and expertise. This includes repair of aortic aneurysms and dissections, minimally invasive and open cardiac surgery for structural heart disease and coronary disease, minimally invasive surgery for atrial fibrillation, and cardiopulmonary transplantation. He has served as the director of Thoracic Aortic Aneurysm at UCLA, the surgical director of Lung and Heart-Lung Transplantation at Stanford University Medical Center and Lucile Packard Children’s Hospital, and Medical Director of Cardiac, Thoracic, and Vascular Surgery at NorthBay Medical Center.

Awards & Honors

Award Conferred By Date
Thoracic Fellowship Teaching Award University of California, San Francisco (UCSF) 2023/2023
ISHLT International Scholarship The International Society for Heart & Lung Transplantation 2012/2013
Laubisch Fund for Cardiovascular Research UCLA School of Medicine 2003/2005
Stein-Oppenheimer Award UCLA School of Medicine 2003/2004
Resident of the Year, John Henry Smith Award Department of Surgery, Stanford University School of Medicine 1992/1992
Alpha Omega Alpha School of Medicine, University of California, Irvine 1990/1990
Walter Blumenson Award for Academic Promise School of Medicine, University of California, Irvine 1990/1990
Regents' Scholarship University of California 1986/1990

Education

Institution Degree Dept or School End Date
University of California, Los Angeles Fellowship/Cardiothoracic Surgery School of Medicine 2001
Stanford University Medical Center Fellowship/Endovascular Fellowship School of Medicine 1998
Stanford University Medical Center Fellowship/Vascular Surgery School of Medicine 1997
Stanford University Post-Doctoral Fellow School of Medicine 1996
Stanford University Medical Center Residency/Surgery School of Medicine 1995
University of California, Irvine M.D./Regents Scholar School of Medicine 1990
The University of Michigan, Ann Arbor B.S. Electrical & Computer Engineering
University of California, Berkeley M.Sc. Electrical Engineering and Computer Science

Board Certifications

American Board of Surgery, General Surgery, American Board of Surgery, Vascular Surgery, American Board of Thoracic Surgery, Thoracic and Cardiac Surgery

Clinical Expertise

Thoracic Aortic Aneurysm and Dissection

Mitral Valve Repair

Heart and Lung Transplantation

Arrhythmia Surgery

Re-operative surgery for coronary and valvular heart disease

Grants and Funding

  • Cardiac Differentiation of Adipose Tissue-Derived Stem Cells by Light Stimulation | NIH | 2011-04-01 - 2013-03-31 | Role: Principal Investigator

Research Narrative

Since 2001 Dr. Beygui has been an active researcher in cardiovascular tissue engineering and stem cell differentiation along the cardiovascular lineage. Dr. Beygui and research collaborators have published their research extensively on myocardial regeneration, mechanisms of cardiac ischemia/reperfusion, tissue regeneration, stem cell differentiation, drug release from nanoparticles in small animal models, and the effects of surface topology on cell surface adhesion molecules. Over the past 4 years Dr. Beygui has collaborated closely with Professor Richard Zare (Stanford University) on the application of nanoparticles on tumor regression and angiogenesis.

Research Interests

Stem Cell Biology

Cardiovascular Tissue Regeneration

Application of Nano Particles in Biomedical Research

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 64
  1. Clinical Improvement With Transcatheter Edge-to-Edge Tricuspid Repair Irrespective of Right Atrial Pressure.
    Ya'Qoub L, Caughron H, Qasim A, Tolstrop K, Delling FN, Watt C, Nguyen T, Deuse T, Beygui RE, Mahadevan VS| | PubMed
  2. Hybrid Endo-Epicardial Therapies for Advanced Atrial Fibrillation.
    Wong CX, Buch EF, Beygui R, Lee RJ| | PubMed
  3. Thrombectomy using AlphaVac for left atrial thrombus causing mechanical mitral valve obstruction and cardiogenic shock.
    Ya'Qoub L, Beygui RE, Shunk K, Agrawal H| | PubMed
  4. Gender-based time discrepancy in diagnosis of coronary artery disease based on data analytics of electronic medical records.
    Panahiazar M, Bishara AM, Chern Y, Alizadehsani R, Islam SMS, Hadley D, Arnaout R, Beygui RE| | PubMed
  5. Data Analytics of Electronic Health Records to Enhance Care of Coronary Artery Disease in Younger Women with Avoiding Possible Delay in Treatment.
    Panahiazar M, Bishara AM, Chern Y, Alizadehsani R, Latif OS, Hadley D, Beygui RE| | PubMed
  6. An Ontology for Cardiothoracic Surgical Education and Clinical Data Analytics.
    Panahiazar M, Chern Y, Riojas R, Latif OS, Lokala U, Hadley D, Sheth A, Beygui RE| | PubMed
  7. Data Analytics of Electronic Medical Record to Study Racial Diversities in Cardiovascular Diagnosis and Treatment.
    Panahiazar M, Chern Y, Riojas R, Latif OS, Hadley D, Beygui RE| | PubMed
  8. Efficacy and mortality of rotating sheaths versus laser sheaths for transvenous lead extraction: a meta-analysis.
    Lee SY, Allen IE, Diaz C, Guo X, Pellegrini C, Beygui R, Cardona-Guarache R, Marcus GM, Lee BK| | PubMed
  9. Coronary artery disease detection using artificial intelligence techniques: A survey of trends, geographical differences and diagnostic features 1991-2020.
    Alizadehsani R, Khosravi A, Roshanzamir M, Abdar M, Sarrafzadegan N, Shafie D, Khozeimeh F, Shoeibi A, Nahavandi S, Panahiazar M, Bishara A, Beygui RE, Puri R, Kapadia S, Tan RS, Acharya UR| | PubMed
  10. Subxiphoid Hybrid Epicardial-Endocardial Atrial Fibrillation Ablation and LAA Ligation: Initial Sub-X Hybrid MAZE Registry Results.
    Ellis CR, Badhwar N, Tschopp D, Danter M, Jackson GG, Kerendi F, Walters T, Fang Q, Deuse T, Beygui R, Lee RJ| | PubMed
  11. Systematic Review of Gender Based Studies of Diagnosis and Treatment of Cardiovascular Disease in Last 20 Years
    Panahiazar M, Alizadehsani R, Bishara AM, Chern, Y, Hadley D, Beygui RE| | UCSF Research Profile
  12. Reported mortality with rotating sheaths vs. laser sheaths for transvenous lead extraction.
    Diaz CL, Guo X, Whitman IR, Marcus GM, Pellegrini CN, Beygui RE, Lee SY, Lee BK| | PubMed
  13. Hybrid and surgical procedures for the treatment of persistent and longstanding persistent atrial fibrillation.
    Sanchez JM, Al-Dosari G, Chu S, Beygui R, Deuse T, Badhwar N, Lee RJ| | PubMed
  14. Carcinoid Syndrome Complicating a Pancreatic Neuroendocrine Tumor: A Case Report.
    Gerson JN, Witteles RM, Chang DT, Beygui RE, Iagaru AH, Kunz PL| | PubMed
  15. Quantification of motion of the thoracic aorta after ascending aortic repair of type-A dissection.
    Suh GY, Fleischmann D, Beygui RE, Cheng CP| | PubMed
  16. Volumetric analysis demonstrates that true and false lumen remodeling persists for 12 months after thoracic endovascular aortic repair.
    Suh GY, Hirotsu K, Beygui RE, Dake MD, Fleischmann D, Cheng CP| | PubMed
  17. Volumetric Analysis Demonstrates True and False Lumen Remodeling Persists for 12 Months after TEVAR
    GY Suh, K Hirotsu, R Beygui, MD Dake, D Fleischmann, CP Cheng| | UCSF Research Profile
  18. Multipotency and cardiomyogenic potential of human adipose-derived stem cells from epicardium, pericardium, and omentum.
    Wystrychowski W, Patlolla B, Zhuge Y, Neofytou E, Robbins RC, Beygui RE| | PubMed
  19. Celecoxib Nanoparticles for Therapeutic Angiogenesis.
    Margulis K, Neofytou EA, Beygui RE, Zare RN| | PubMed
  20. Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties.
    Neofytou E, Deuse T, Beygui RE, Schrepfer S| | PubMed
  21. Immunobiology of fibrin-based engineered heart tissue.
    Conradi L, Schmidt S, Neofytou E, Deuse T, Peters L, Eder A, Hua X, Hansen A, Robbins RC, Beygui RE, Reichenspurner H, Eschenhagen T, Schrepfer S| | PubMed
  22. Cardiac metastases and tumor embolization: A rare sequelae of primary undifferentiated liver sarcoma.
    Dua MM, Cloyd JM, Haddad F, Beygui RE, Norton JA, Visser BC| | PubMed
  23. Aortic arch vessel geometries and deformations in patients with thoracic aortic aneurysms and dissections.
    Suh GY, Beygui RE, Fleischmann D, Cheng CP| | PubMed
  24. Multidisciplinary treatment for thoracic and abdominopelvic endometriosis.
    Nezhat C, Main J, Paka C, Nezhat A, Beygui RE| | PubMed
  25. Wireless power transfer to deep-tissue microimplants.
    Ho JS, Yeh AJ, Neofytou E, Kim S, Tanabe Y, Patlolla B, Beygui RE, Poon AS| | PubMed
  26. Congenital anomalies of the aortic arch in acute type-a aortic dissection: implications for monitoring, perfusion strategy, and surgical repair.
    Maxwell BG, Harrington KB, Beygui RE, Oakes DA| | PubMed
  27. A histological and mechanical analysis of the cardiac lead-tissue interface: implications for lead extraction.
    Rennert RC, Rustad K, Levi K, Harwood M, Sorkin M, Wong VW, Al-Ahmad A, Zei P, Hsia H, Beygui RE, Norton L, Wang P, Gurtner GC| | PubMed
  28. Human pluripotent stem cell tools for cardiac optogenetics.
    Zhuge Y, Patlolla B, Ramakrishnan C, Beygui RE, Zarins CK, Deisseroth K, Kuhl E, Abilez OJ| | PubMed
  29. Robust pluripotent stem cell expansion and cardiomyocyte differentiation via geometric patterning.
    Myers FB, Silver JS, Zhuge Y, Beygui RE, Zarins CK, Lee LP, Abilez OJ| | PubMed
  30. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.
    Navarrete EG, Liang P, Lan F, Sanchez-Freire V, Simmons C, Gong T, Sharma A, Burridge PW, Patlolla B, Lee AS, Wu H, Beygui RE, Wu SM, Robbins RC, Bers DM, Wu JC| | PubMed
  31. Right-ventricular failure following left ventricle assist device implantation.
    Patlolla B, Beygui R, Haddad F| | PubMed
  32. Protein-polymer hybrid nanoparticles for drug delivery.
    Ge J, Neofytou E, Lei J, Beygui RE, Zare RN| | PubMed
  33. Bilateral thoracic endometriosis affecting the lung and diaphragm.
    Nezhat C, King LP, Paka C, Odegaard J, Beygui R| | PubMed
  34. Drug release from electric-field-responsive nanoparticles.
    Ge J, Neofytou E, Cahill TJ, Beygui RE, Zare RN| | PubMed
  35. Mediastinal goiter: a comprehensive study of 60 consecutive cases with special emphasis on identifying predictors of malignancy and sternotomy.
    Hajhosseini B, Montazeri V, Hajhosseini L, Nezami N, Beygui RE| | PubMed
  36. Successful use of a pneumatic biventricular assist device as a bridge to transplantation in cardiogenic shock.
    Moriguchi J, Davis S, Jocson R, Esmailian F, Ardehali A, Laks H, Kwon M, Kittleson M, Kobashigawa J, Patel J, Marelli D, Plunkett M, Beygui R, Shemin R| | PubMed
  37. Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds.
    Neofytou EA, Chang E, Patlola B, Joubert LM, Rajadas J, Gambhir SS, Cheng Z, Robbins RC, Beygui RE| | PubMed
  38. A matrix micropatterning platform for cell localization and stem cell fate determination.
    Huang NF, Patlolla B, Abilez O, Sharma H, Rajadas J, Beygui RE, Zarins CK, Cooke JP| | PubMed
  39. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, Beygui R, Shemin R, Watson L, Vartapetian I, Ardehali A| | PubMed
  40. Endometriosis of the diaphragm: four cases treated with a combination of laparoscopy and thoracoscopy.
    Nezhat C, Nicoll LM, Bhagan L, Huang JQ, Bosev D, Hajhosseini B, Beygui RE| | PubMed
  41. The use of three-dimensional nanostructures to instruct cells to produce extracellular matrix for regenerative medicine strategies.
    Schenke-Layland K, Rofail F, Heydarkhan S, Gluck JM, Ingle NP, Angelis E, Choi CH, MacLellan WR, Beygui RE, Shemin RJ, Heydarkhan-Hagvall S| | PubMed
  42. Cell growth as a sheet on three-dimensional sharp-tip nanostructures.
    Choi CH, Heydarkhan-Hagvall S, Wu BM, Dunn JC, Beygui RE, Kim CJ| | PubMed
  43. Tricuspid valve regurgitation after heart transplantation.
    Marelli D, Esmailian F, Wong SY, Kobashigawa JA, Kwon MH, Beygui RE, Laks H, Plunkett MD, Ardehali A, Shemin RJ| | PubMed
  44. Long-term outcomes of heart transplantation in older recipients.
    Marelli D, Kobashigawa J, Hamilton MA, Moriguchi JD, Kermani R, Ardehali A, Patel J, Noguchi E, Beygui R, Laks H, Plunkett M, Shemin R, Esmailian F| | PubMed
  45. Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering.
    Heydarkhan-Hagvall S, Schenke-Layland K, Dhanasopon AP, Rofail F, Smith H, Wu BM, Shemin R, Beygui RE, MacLellan WR| | PubMed
  46. Human adipose stem cells: a potential cell source for cardiovascular tissue engineering.
    Heydarkhan-Hagvall S, Schenke-Layland K, Yang JQ, Heydarkhan S, Xu Y, Zuk PA, MacLellan WR, Beygui RE| | PubMed
  47. Hypoxic cell death is reduced by pH buffering in a model of engineered heart tissue.
    Brown DA, MacLellan WR, Dunn JC, Wu BM, Beygui RE| | PubMed
  48. Lung transplantation in older patients?
    Mahidhara R, Bastani S, Ross DJ, Saggar R, Lynch J, Schnickel GT, Gjertson D, Beygui R, Ardehali A| | PubMed
  49. Donor brain death mechanisms and outcomes after heart transplantation.
    Cohen O, De La Zerda DJ, Beygui R, Hekmat D, Laks H| | PubMed
  50. Ethnicity as a predictor of graft longevity and recipient mortality in heart transplantation.
    Cohen O, De La Zerda D, Beygui RE, Hekmat D, Laks H| | PubMed
  51. Influence of systematically varied nano-scale topography on cell morphology and adhesion.
    Heydarkhan-Hagvall S, Choi CH, Dunn J, Heydarkhan S, Schenke-Layland K, MacLellan WR, Beygui RE| | PubMed
  52. The role of cytoprotective cytokines in cardiac ischemia/reperfusion injury.
    Anderson CD, Heydarkhan-Hagvall S, Schenke-Layland K, Yang JQ, Jordan MC, Kim JK, Brown DA, Zuk PA, Laks H, Roos KP, Maclellan WR, Beygui RE| | PubMed
  53. Analysis of pH gradients resulting from mass transport limitations in engineered heart tissue.
    Brown DA, Maclellan WR, Wu BM, Beygui RE| | PubMed
  54. Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue.
    Brown DA, MacLellan WR, Laks H, Dunn JC, Wu BM, Beygui RE| | PubMed
  55. Alcohol use in donors is a protective factor on recipients' outcome after heart transplantation.
    De La Zerda DJ, Cohen O, Beygui RE, Kobashigawa J, Hekmat D, Laks H| | PubMed
  56. Cell interaction with three-dimensional sharp-tip nanotopography.
    Choi CH, Hagvall SH, Wu BM, Dunn JC, Beygui RE, CJ Kim CJ| | PubMed
  57. Modified reperfusion in clinical lung transplantation: the results of 100 consecutive cases.
    Schnickel GT, Ross DJ, Beygui R, Shefizadeh A, Laks H, Saggar R, Lynch JP, Ardehali A| | PubMed
  58. Modulation of gene expression in neonatal rat cardiomyocytes by surface modification of polylactide-co-glycolide substrates.
    Brown DA, Beygui RE, MacLellan WR, Laks H, Dunn JC, Wu BM| | PubMed
  59. Gelatin-embedded cell-polymer constructs for histological cryosectioning.
    Brown DA, Chou YF, Beygui RE, Dunn JC, Wu BM| | PubMed
  60. Expression of cardiomyocytic markers on adipose tissue-derived cells in a murine model of acute myocardial injury.
    Strem BM, Zhu M, Alfonso Z, Daniels EJ, Schreiber R, Beygui R, Begyui R, MacLellan WR, Maclellan WR, Hedrick MH, Fraser JK| | PubMed
  61. Repair of the symptomatic aberrant aortic arch aneurysm without hypothermic circulatory arrest.
    Beygui RE, Esmailian F, Rigberg DA, Laks H| | PubMed
  62. Prevention of spinal cord ischemia in an ovine model of abdominal aortic aneurysm treated with a self-expanding stent-graft.
    Beygui RE, Kinney EV, Pelc LR, Krievins D, Whittemore J, Fogarty TJ, Zarins CK| | PubMed
  63. Subclavian vein thrombosis: outcome analysis based on etiology and modality of treatment.
    Beygui RE, Olcott C, Dalman RL| | PubMed
  64. Etiology of aortic aneurysm.
    Zarins CK, Beygui RE| | PubMed